Leading cardiovascular organizations call for urgent action to reduce air pollution

January 28, 2021

Air pollution is a key risk factor for cardiovascular disease, and a major contributor to the global burden of disease. Long-term exposure to air pollution has also been linked to an increased risk of death from COVID-19. This dangerous "triple threat" of air pollution, COVID-19 and cardiovascular disease should be taken seriously, warn major health authorities.

Four leading cardiovascular organizations - the World Heart Federation (WHF), American College of Cardiology (ACC), American Heart Association (AHA) and European Society of Cardiology (ESC) - today released a joint statement urging the medical community and health authorities to mitigate the impact of air pollution on people's health.

In 2019, an estimated 6.7 million deaths, or 12 percent of all deaths worldwide, were attributable to outdoor or household air pollution.[1] As many as half of these were due to cardiovascular disease. Air pollution also increases the risk of heart attack, stroke, diabetes and respiratory diseases, which are known to raise a person's risk of experiencing some of the more severe consequences of COVID-19.

"Even before the COVID-19 pandemic, air pollution was an issue of growing concern due to its impact on people's health, although it was frequently overlooked as a risk factor for cardiovascular disease. COVID-19 has brought a new, deadly factor to the equation, and the time has come for the health community to speak up and take action," said Michael Brauer, Chair of the World Heart Federation Air Pollution Expert Group and co-author of the statement.

The statement calls for structural actions to reduce emissions of air pollutants and harmful exposure. It also highlights the important role that healthcare providers play in preventing illnesses related to air pollution, including:
-end-
The statement will be published simultaneously in the flagship journals of all four organizations: the Journal of the American College of Cardiology (JACC), the Journal of the American Heart Association (JAHA), the European Heart Journal (EHJ) and Global Heart.

Notes to Editors

Quote ACC:"Clinicians have a responsibility to educate their patients, their colleagues and their communities at large on the connection between air pollution and cardiovascular disease risk," said Richard Kovacs, MD, MACC, senior author of the joint statement and ACC Immediate Past President. "By advocating for recognition of air pollution as a health factor, working individually with our patients to reduce exposure and associated risks, and integrating air pollution into broader disease management approaches, the health care community can provide support for larger pollution mitigation efforts."

Quote AHA:"Poor air quality can harm heart and brain health, with a disproportionate impact on low-income and poor communities located near sources of air pollution," said Robert Harrington, M.D., FAHA, Arthur L. Bloomfield Professor of Medicine and Chair of the Department of Medicine at Stanford University, Immediate Past President of the American Heart Association and a co-author of the statement. "We must address this problem as a global community to equitably reduce exposure to air pollution and reverse the health harms of poor air quality for all."

Quote ESC:"Air pollution is one of the most underestimated causes of heart disease and stroke," said Professor Stephan Achenbach, President of the European Society of Cardiology. "More research is urgently required to identify susceptible populations and to determine the optimal methods of improving air quality to benefit cardiovascular health. Air pollution needs to be recognized as a major modifiable risk factor in the prevention and management of cardiovascular disease, and measures to reduce its detrimental short-term and long-term influence on cardiovascular health, potentially over generations, are urgently required."

About the American College of Cardiology (ACC)

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.

About the American Heart Association (AHA)

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public's health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

About the European Society of Cardiology (ESC)

The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.

About the World Heart Federation (WHF)

The World Heart Federation (WHF) unites the cardiovascular community and drives the agenda to reduce the global burden of cardiovascular disease and help people live longer, healthier lives. Together with our Members, we are working to end needless deaths and build global commitment for improved cardiovascular health at the global, regional, national and community levels. We believe in a world where heart health for everyone is a fundamental human right.

To learn more, visit worldheart.org.

Media Contacts

Dana Kauffman, Media Relations Associate, ACC, dkauffman@acc.org
Suzette Harris, Media Advocacy Director, AHA, suzette.harris@heart.org
Jackie Partarrieu, Media Team Manager, ESC, press@escardio.org
Mihela Kralj, Communications Manager, WHF, mihela.kralj@worldheart.org

[1] Institute for Health Metrics and Evaluation, 2020

American College of Cardiology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.